Page 1 of 4 No. RJH – SET 8/2019 13 May 2019 Subject : Management’s Discussion and Analysis for the First Quarter of 2019 To : The President The Stock Exchange of Thailand Rajthanee Hospital Public
2nd quarter ended 30 June 2019 Attn: Director and Manager, The Stock Exchange of Thailand With respect to the financial information for the 2nd quarter ended 30 June 2019, as submitted by the Company
Page 1 of 4 No. RJH – SET 7/2018 11 May 2018 Subject : Management’s Discussion and Analysis for the 1st quarter of 2018 ending March 31, 2018 To : The President The Stock Exchange of Thailand
หนังสือแสดงการรับทราบความผิด 14 August 2018 Subject : Management Discussion and Analysis of the second quarter 2018 ended 30 June 2018 Attn. : Director and Manager The Stock Exchange of Thailand
Page 1 of 4 No. RJH – SET 16/2019 11 November 2019 Subject : Management’s Discussion and Analysis for the 3rd Quarter of 2019 To : The President The Stock Exchange of Thailand Rajthanee Hospital
Microsoft Word - MDA Q319 EN.docx November 11, 2019 To President The Stock Exchange of Thailand Subject Notification on the difference of revenue from sales and net profit YOY by more than 20 percent
Page 1 of 4 No. RJH – SET 9/2020 10 August 2020 Subject : Management’s Discussion and Analysis for the Second Quarter of 2020 To : The President The Stock Exchange of Thailand Rajthanee Hospital
August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
No. ADD 4/2022 23 February 2022 Subject: Management discussion and analysis for the performance of the year 2021 ended 31 December 2021 To: President The Stock Exchange of Thailand AddTech Hub Public
No. ADD 19/2022 11 May 2022 Subject: Management discussion and analysis for the performance for the three-month period ended 31 March 2022 To: President The Stock Exchange of Thailand AddTech Hub